Outcome implications of the International Maternal Phenylketonuria Collaborative Study (MPKUCS): 1994. 1996

R Koch, and H Levy, and W Hanley, and R Matalon, and B Rouse, and F Trefz, and F de la Cruz
Childrens Hospital Los Angeles, Division of Medical Genetics, CA 90027, USA.

It is well established that women with phenylketonuria who remain untreated during pregnancy face serious problems in offspring outcome. Surveys have documented that maternal phenylalanine (Phe) blood concentrations above 1200 mumol/l are associated with microcephaly, congenital heart disease and intrauterine growth retardation among their offspring. To investigate the efficacy of the Phe restricted diet, the National Institute of Child Health and Human Development in Bethesda Maryland developed an international study to evaluate fetal outcome in pregnancies treated with the Phe restricted diet. The study involves over 100 metabolic clinics in the United States, Canada and Germany, and is now in its 10th year. The results included in this report are still preliminary in nature and the actual risk for such pregnancies remains to be determined.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015337 Multicenter Studies as Topic Works about controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children. Multicenter Trials,Multicentre Studies as Topic,Multicentre Trials,Multicenter Trial,Multicentre Trial,Trial, Multicenter,Trial, Multicentre,Trials, Multicenter,Trials, Multicentre
D017042 Phenylketonuria, Maternal A condition occurring in untreated or partially treated females with PHENYLKETONURIA when they become pregnant. This may result in damages to the FETUS, including MICROCEPHALY; MENTAL RETARDATION; congenital heart disease; FETAL GROWTH RETARDATION; and CRANIOFACIAL ABNORMALITIES. (From Am J Med Genet 1997 Mar 3;69(1):89-95) Maternal Phenylalanine Hydroxylase Deficiency Disease,Pregnancy in Phenylketonuria,Maternal Phenylketonuria,PKU, Maternal,Phenylalanine-Hydroxylase Deficiency Disease, Maternal,Phenylalanine Hydroxylase Deficiency Disease, Maternal,Phenylketonuria, Pregnancy in
D018753 Diet, Protein-Restricted A diet that contains limited amounts of protein. It is prescribed in some cases to slow the progression of renal failure. (From Segen, Dictionary of Modern Medicine, 1992) Diet, Low-Protein,Diet, Protein-Free,Low-Protein Diet,Protein-Restricted Diet,Diet, Low Protein,Diet, Protein Free,Diet, Protein Restricted,Diets, Low-Protein,Diets, Protein-Free,Diets, Protein-Restricted,Low Protein Diet,Low-Protein Diets,Protein Restricted Diet,Protein-Free Diet,Protein-Free Diets,Protein-Restricted Diets

Related Publications

R Koch, and H Levy, and W Hanley, and R Matalon, and B Rouse, and F Trefz, and F de la Cruz
October 2000, European journal of pediatrics,
R Koch, and H Levy, and W Hanley, and R Matalon, and B Rouse, and F Trefz, and F de la Cruz
January 2004, Journal of inherited metabolic disease,
R Koch, and H Levy, and W Hanley, and R Matalon, and B Rouse, and F Trefz, and F de la Cruz
November 1994, Nutrition reviews,
R Koch, and H Levy, and W Hanley, and R Matalon, and B Rouse, and F Trefz, and F de la Cruz
January 2014, Journal of inherited metabolic disease,
R Koch, and H Levy, and W Hanley, and R Matalon, and B Rouse, and F Trefz, and F de la Cruz
October 1987, Lancet (London, England),
R Koch, and H Levy, and W Hanley, and R Matalon, and B Rouse, and F Trefz, and F de la Cruz
November 1981, European journal of obstetrics, gynecology, and reproductive biology,
R Koch, and H Levy, and W Hanley, and R Matalon, and B Rouse, and F Trefz, and F de la Cruz
August 1988, Acta paediatrica Japonica : Overseas edition,
R Koch, and H Levy, and W Hanley, and R Matalon, and B Rouse, and F Trefz, and F de la Cruz
November 1980, The New England journal of medicine,
R Koch, and H Levy, and W Hanley, and R Matalon, and B Rouse, and F Trefz, and F de la Cruz
March 1997, American journal of medical genetics,
R Koch, and H Levy, and W Hanley, and R Matalon, and B Rouse, and F Trefz, and F de la Cruz
July 1996, European journal of pediatrics,
Copied contents to your clipboard!